Didier Desmaele

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Institut Gustave Roussy, National Institute of Health and Medical Research. Active years: 2003-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Desmaele. Retrieved from https://idiyas.com/inventor/didier-desmaele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 55.6

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

5 out of 5,383

Centre National De La Recherche Scientifique

patents

5 out of 101

Institut Gustave Roussy

patents

2 out of 1,853

National Institute of Health and Medical Research

Bioalliance Pharma Sa

National Institute for Agricultural Research

patents

8. 1 out of 3

Universite De Paris 11 - Paris Sud

patents

9. 1 out of 7

Université Paris Sud-Paris Xi

University of Paris Sud XI

patents

12. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2019

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10213413 - Antiviral agents directed against respiratory syncytial virus (2019-02-26),

2. 10125157 - Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation (2018-11-13),

3. 10098901 - Derivatives of oxazaphosphorines and therapeutic uses thereof (2018-10-16),

4. 9428530 - Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation (2016-08-30),

5. 9295630 - Vitamin C complexes (2016-03-29),

6. 8748414 - Statin nanoparticles (2014-06-10),

7. 7479497 - Use of quinoline derivatives with anti-integrase effect and applications thereof (2009-01-20),

8. 7064133 - Quinoline derivatives process of synthesis and medicaments containing these derivatives (2006-06-20),

9. 6670377 - Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof (2003-12-30),

Title: The Innovative Contributions of Didier Desmaele

Introduction

Didier Desmaele is a prominent inventor based in Fresnes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents and cancer treatments. With a total of nine patents to his name, Desmaele's work has had a considerable impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents, one notable invention is focused on antiviral agents directed against respiratory syncytial virus. This invention relates to N1-benzyl substituted pyrazoles, which serve as effective antiviral agents. Another significant patent involves derivatives of oxazaphosphorines that are pre-activated. This invention details the methods for preparing these derivatives, the pharmaceutical compositions containing them, and their therapeutic use, particularly in treating cancer.

Career Highlights

Desmaele has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Institut Gustave Roussy. His career has been marked by a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Desmaele has collaborated with notable professionals in the field, including Patrick Couvreur and Jean D'Angelo. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Didier Desmaele's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the development of effective treatments for viral infections and cancer.

Profile summary based on public USPTO records.